{"id":2445,"date":"2020-12-20T23:40:43","date_gmt":"2020-12-20T23:40:43","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2445"},"modified":"2023-08-29T18:01:54","modified_gmt":"2023-08-29T18:01:54","slug":"incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2445","title":{"rendered":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IHL&amp;lang=cn\">Incannex Healthcare (ASX: IHL)<\/a>\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u8fd9\u9879\u8bd5\u9a8c\u5c06\u8003\u5bdfIncannex\u7684\u5019\u9009\u836f\u7269IHL-42X\u6cbb\u7597OSA\u7684\u6548\u679c\u3002OSA\u662f\u4e00\u79cd\u9ad8\u5ea6\u6d41\u884c\u7684\u75be\u75c5\uff0c\u53ef\u8010\u53d7\u7684\u6cbb\u7597\u9009\u9879\u6709\u9650\uff0c\u5f71\u54cd\u7740\u5168\u7403\u903e3000\u4e07\u4eba\u3002<\/p>\n<p>\u7f8e\u56fd\u533b\u7597\u4fdd\u5065\u7cfb\u7edf\u6bcf\u5e74\u8981\u82b1\u8d391496\u4ebf\u7f8e\u5143(1940\u4ebf\u6fb3\u5143)\u6765\u6cbb\u7597\u8fd9\u79cd\u75be\u75c5\uff0c\u800c\u76ee\u524d\u8fd8\u6ca1\u6709\u83b7\u5f97\u6279\u51c6\u7684\u836f\u7269\u6cbb\u7597\u3002<\/p>\n<p>\u6839\u636e\u5fb7\u52e4\u7ecf\u6d4e\u54a8\u8be2\u516c\u53f8(Deloitte Access Economics)\u7684\u6570\u636e\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\uff0c\u6bcf\u5e74\u7684\u76f4\u63a5\u7ecf\u6d4e\u6210\u672c\u8d85\u8fc7210\u4ebf\u6fb3\u5143\u3002<\/p>\n<p>Incannex\u8ba1\u5212\u5f00\u5c55\u4e00\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u63a7\u5236\u5242\u91cf\u8303\u56f4\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u4e09\u79cd\u4e0d\u540c\u5242\u91cf\u7684IHL-42X\u7684\u6cbb\u7597\u6548\u76ca\u3002<em>Small Caps<\/em>\u5728\u4eca\u5e747\u6708<a href=\"http:\/\/smallcaps-production.test\/incannex-the-alfred-hospital-phase-2b-clinical-trial-study-cannabinoid-drug-obstructive-sleep-apnoea\/?lang=cn\">\u9996\u6b21\u62a5\u9053\u4e86\u8fd9\u4e9b\u8ba1\u5212<\/a>\u3002<\/p>\n<p>Incannex\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406Joel Latham\u8868\u793a:\u201cIncannex\u7684\u6574\u4e2a\u56e2\u961f\u5f88\u9ad8\u5174\u5df2\u7ecf\u5f00\u59cb\u7b5b\u67e5\uff0c\u5e76\u6b63\u5f0f\u62db\u52df\u7b2c\u4e00\u6279\u60a3\u8005\u53c2\u52a0\u5176\u9996\u6b21\u4eba\u4f53\u8bd5\u9a8c\u3002\u201d<\/p>\n<h2>\u6cbb\u7597\u7761\u7720\u547c\u5438\u6682\u505c<\/h2>\n<p>\u5373\u5c06\u5230\u6765\u7684\u7814\u7a76\u7684\u4e3b\u8981\u7126\u70b9\u662f\u786e\u5b9a\u4e0e\u57fa\u7ebf\u6216\u6cbb\u7597\u524d\u6c34\u5e73\u76f8\u6bd4\uff0c\u8be5\u836f\u7269\u51cf\u5c11OSA\u7684\u7a0b\u5ea6\u3002<\/p>\n<p>\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8be5\u8bd5\u9a8c\u88ab\u5f52\u7c7b\u4e3a\u201c\u4ea4\u53c9\u7814\u7a76\u201d\uff0c\u5373\u6240\u6709\u53c2\u4e0e\u8005\u5c06\u63a5\u53d7\u4e09\u5242\uff0c\u5916\u52a0\u4e00\u5242\u5b89\u6170\u5242\u3002\u75c5\u4eba\u5c06\u7ecf\u5386\u56db\u4e2a\u7597\u7a0b\uff0c\u6bcf\u4e2a\u7597\u7a0b\u7684\u5242\u91cf\u4e0d\u540c\u3002<\/p>\n<p>\u8be5\u5236\u836f\u516c\u53f8\u8868\u793a\uff0c\u6b64\u540e\uff0c\u6cbb\u7597\u671f\u95f4\u5c06\u88ab\u201c\u6d17\u8131\u671f\u201d\u5206\u5f00\uff0c\u4ee5\u4f7f\u836f\u7269\u4ece\u7cfb\u7edf\u4e2d\u6e05\u9664\u3002<\/p>\n<p>\u8fdb\u4e00\u6b65\u4e86\u89e3\u7269\u6d41\u7684\u4e34\u5e8a\u8bd5\u9a8c,Incannex\u900f\u9732,\u5728\u6bcf\u4e2a\u6cbb\u7597\u5468\u671f\u7684\u6700\u540e\u4e00\u591c,\u4e3b\u9898\u5c06\u8bbf\u95ee\u5728\u963f\u5c14\u5f17\u96f7\u5fb7\u533b\u9662(Alfred Hospital)\u7761\u7720\u8bca\u6240,\u4ed6\u4eec\u7684\u7761\u7720\u8bc4\u4f30\u4f7f\u7528\u201c\u591c\u95f4\u591a\u5bfc\u7761\u7720\u56fe\u201d,\u6d4b\u91cf\u7684\u6709\u6548\u6027\u5c06\u4e0e\u4e00\u4e2a\u884c\u4e1a\u6807\u51c6,\u5426\u5219\u79f0\u4e3a\u547c\u5438\u6682\u505c\u547c\u5438\u4e0d\u8db3\u6307\u6570(AHI)\u3002<\/p>\n<p>\u5728\u8fd9\u4e9b\u8bca\u6240\u8bbf\u95ee\u671f\u95f4\uff0c\u5c06\u5b8c\u6210\u8c03\u67e5\uff0c\u901a\u8fc7\u91c7\u96c6\u8840\u6db2\u6837\u672c\u76d1\u6d4b\u6b21\u8981\u7ec8\u70b9\uff0c\u4ee5\u76d1\u6d4bIncannex\u5019\u9009\u836f\u7269\u7684\u5b89\u5168\u6027\u3002<\/p>\n<h2>\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c<\/h2>\n<p>Incannex\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u5c06\u5728Alfred\u533b\u9662\u8fdb\u884c\uff0c\u7531\u8d44\u6df1\u9996\u5e2d\u7814\u7a76\u5458Terry O &#8216;Brien\u6559\u6388\u6307\u5bfc\u3002<\/p>\n<p>\u6839\u636e\u8bd5\u9a8c\u7684\u65e2\u5b9a\u76ee\u6807\uff0c\u8fd8\u5c06\u76d1\u6d4b\u53c2\u4e0e\u8005\u7684\u5176\u4ed6\u7ec8\u70b9\uff0c\u5982\u6c27\u9971\u548c\u5ea6\u6307\u6570\u7684\u964d\u4f4e\u3001\u767d\u5929\u7684\u55dc\u7761\u3001\u60c5\u7eea\u548c\u751f\u6d3b\u8d28\u91cf\u3002<\/p>\n<p>\u9274\u4e8e\u201c\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u5728\u766b\u75eb\u60a3\u8005\u4e2d\u6bd4\u666e\u901a\u4eba\u7fa4\u66f4\u666e\u904d\uff0c\u800c\u4e14\u7761\u7720\u8d28\u91cf\u5dee\u4e0e\u766b\u75eb\u53d1\u4f5c\u9891\u7387\u9ad8\u6709\u5173\u201d\uff0c\u8be5\u516c\u53f8\u6307\u51fa\uff0c\u766b\u75eb\u60a3\u8005\u53ef\u80fd\u662f\u8be5\u836f\u6cbb\u7597\u4e2d\u6700\u6025\u6027\u7684\u53d7\u76ca\u8005\u3002<\/p>\n<p>Incannex\u8865\u5145\u8bf4\uff0cO &#8216;Brien\u5148\u751f\u63a5\u89e6\u60a3\u6709\u5171\u75c5\u6027\u766b\u75eb\u548cOSA\u7684\u60a3\u8005\u5c06\u6709\u52a9\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8fdb\u5c55\uff0c\u5e76\u4f7f\u516c\u53f8\u80fd\u591f\u8bc4\u4f30IHL-42X\u7597\u6548\u7684\u6539\u5584\u662f\u5426\u4f1a\u964d\u4f4e\u766b\u75eb\u53d1\u4f5c\u7684\u9891\u7387\u3002<\/p>\n<p>\u5982\u679c\u8bd5\u9a8c\u6210\u529f\uff0cIncannex\u5e0c\u671b\u901a\u8fc7\u6fb3\u5927\u5229\u4e9a\u7684\u7279\u6b8a\u51c6\u5165\u8ba1\u5212\uff0c\u5c06IHL-42X\u4e0e\u5927\u9ebb\u7d20\u6cb9\u548cCBD\u5438\u5165\u5668\u4e00\u8d77\u5728\u6fb3\u5927\u5229\u4e9a\u9500\u552e\u3002\u6b64\u540e\uff0c\u8be5\u516c\u53f8\u5e0c\u671b\u8fdb\u884c\u7b2c\u4e8c\u9636\u6bb5\u7684\u201c\u6790\u56e0\u4e34\u5e8a\u8bd5\u9a8c\u201d\uff0c\u56e0\u4e3a\u5b83\u7f16\u8f91\u5fc5\u8981\u7684\u4fe1\u606f\uff0c\u4e3a\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u7684\u65b0\u836f\u7533\u8bf7\uff0c\u4ee5\u5b9e\u73b0\u5728\u7f8e\u56fd\u7684\u5e02\u573a\u72ec\u5360\u6027\u3002<\/p>\n<p>Incannex\u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u58f0\u660e\u4e2d\u8868\u793a\uff0c\u5982\u679cAlfred\u7684\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u79ef\u6781\u7684\u7ed3\u679c\u201d\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6210\u4e3a\u8be5\u516c\u53f8\u201c\u4e3b\u8981\u7684\u4f30\u503c\u8f6c\u6298\u70b9\u201d\u3002<\/p>\n<p>Latham\u8bf4:\u201c\u7761\u7720\u547c\u5438\u6682\u505c\u75c7\u662f\u4e00\u79cd\u5371\u9669\u7684\u75be\u75c5\uff0c\u5bf9\u60a3\u8005\u7684\u5f71\u54cd\u5e7f\u6cdb\uff0c\u76ee\u524d\u7684\u6cbb\u7597\u65b9\u6848\u5bf9\u8bb8\u591a\u4eba\u6765\u8bf4\u4e0d\u5207\u5b9e\u9645\u3002\u201d<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u4e00\u4e2a\u6210\u529f\u7684\u836f\u7269\u89e3\u51b3\u65b9\u6848\u5c06\u5bf9\u8fd9\u79cd\u60c5\u51b5\u7684\u60a3\u8005\u6765\u8bf4\u662f\u9769\u547d\u6027\u7684\uff0c\u6211\u4eec\u671f\u5f85\u7740\u63d0\u4f9b\u4e34\u5e8a\u9879\u76ee\u7684\u66f4\u65b0\uff0c\u56e0\u4e3a\u6211\u4eec\u6b63\u5728\u4e3a\u60a3\u8005\u7ed9\u836f\u6211\u4eec\u72ec\u7279\u7684IHL-42X\u914d\u65b9\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u8fd9\u9879\u8bd5\u9a8c\u5c06\u8003\u5bdfIncannex\u7684\u5019\u9009\u836f\u7269IHL-42X\u6cbb\u7597OSA\u7684\u6548\u679c\u3002OSA\u662f\u4e00\u79cd\u9ad8\u5ea6\u6d41\u884c\u7684\u75be\u75c5\uff0c\u53ef\u8010\u53d7\u7684\u6cbb\u7597\u9009\u9879\u6709\u9650\uff0c\u5f71\u54cd\u7740\u5168\u7403\u903e3000\u4e07\u4eba\u3002 \u7f8e\u56fd\u533b\u7597\u4fdd\u5065\u7cfb\u7edf\u6bcf\u5e74\u8981\u82b1\u8d391496\u4ebf\u7f8e\u5143(1940\u4ebf\u6fb3\u5143)\u6765\u6cbb\u7597\u8fd9\u79cd\u75be\u75c5\uff0c\u800c\u76ee\u524d\u8fd8\u6ca1\u6709\u83b7\u5f97\u6279\u51c6\u7684\u836f\u7269\u6cbb\u7597\u3002 \u6839\u636e\u5fb7\u52e4\u7ecf\u6d4e\u54a8\u8be2\u516c\u53f8(Deloitte Access Economics)\u7684\u6570\u636e\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\uff0c\u6bcf\u5e74\u7684\u76f4\u63a5\u7ecf\u6d4e\u6210\u672c\u8d85\u8fc7210\u4ebf\u6fb3\u5143\u3002 Incannex\u8ba1\u5212\u5f00\u5c55\u4e00\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u63a7\u5236\u5242\u91cf\u8303\u56f4\u76842b\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u4e09\u79cd\u4e0d\u540c\u5242\u91cf\u7684IHL-42X\u7684\u6cbb\u7597\u6548\u76ca\u3002Small Caps\u5728\u4eca\u5e747\u6708\u9996\u6b21\u62a5\u9053\u4e86\u8fd9\u4e9b\u8ba1\u5212\u3002 Incannex\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406Joel Latham\u8868\u793a:\u201cIncannex\u7684\u6574\u4e2a\u56e2\u961f\u5f88\u9ad8\u5174\u5df2\u7ecf\u5f00\u59cb\u7b5b\u67e5\uff0c\u5e76\u6b63\u5f0f\u62db\u52df\u7b2c\u4e00\u6279\u60a3\u8005\u53c2\u52a0\u5176\u9996\u6b21\u4eba\u4f53\u8bd5\u9a8c\u3002\u201d \u6cbb\u7597\u7761\u7720\u547c\u5438\u6682\u505c \u5373\u5c06\u5230\u6765\u7684\u7814\u7a76\u7684\u4e3b\u8981\u7126\u70b9\u662f\u786e\u5b9a\u4e0e\u57fa\u7ebf\u6216\u6cbb\u7597\u524d\u6c34\u5e73\u76f8\u6bd4\uff0c\u8be5\u836f\u7269\u51cf\u5c11OSA\u7684\u7a0b\u5ea6\u3002 \u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8be5\u8bd5\u9a8c\u88ab\u5f52\u7c7b\u4e3a\u201c\u4ea4\u53c9\u7814\u7a76\u201d\uff0c\u5373\u6240\u6709\u53c2\u4e0e\u8005\u5c06\u63a5\u53d7\u4e09\u5242\uff0c\u5916\u52a0\u4e00\u5242\u5b89\u6170\u5242\u3002\u75c5\u4eba\u5c06\u7ecf\u5386\u56db\u4e2a\u7597\u7a0b\uff0c\u6bcf\u4e2a\u7597\u7a0b\u7684\u5242\u91cf\u4e0d\u540c\u3002 \u8be5\u5236\u836f\u516c\u53f8\u8868\u793a\uff0c\u6b64\u540e\uff0c\u6cbb\u7597\u671f\u95f4\u5c06\u88ab\u201c\u6d17\u8131\u671f\u201d\u5206\u5f00\uff0c\u4ee5\u4f7f\u836f\u7269\u4ece\u7cfb\u7edf\u4e2d\u6e05\u9664\u3002 \u8fdb\u4e00\u6b65\u4e86\u89e3\u7269\u6d41\u7684\u4e34\u5e8a\u8bd5\u9a8c,Incannex\u900f\u9732,\u5728\u6bcf\u4e2a\u6cbb\u7597\u5468\u671f\u7684\u6700\u540e\u4e00\u591c,\u4e3b\u9898\u5c06\u8bbf\u95ee\u5728\u963f\u5c14\u5f17\u96f7\u5fb7\u533b\u9662(Alfred Hospital)\u7761\u7720\u8bca\u6240,\u4ed6\u4eec\u7684\u7761\u7720\u8bc4\u4f30\u4f7f\u7528\u201c\u591c\u95f4\u591a\u5bfc\u7761\u7720\u56fe\u201d,\u6d4b\u91cf\u7684\u6709\u6548\u6027\u5c06\u4e0e\u4e00\u4e2a\u884c\u4e1a\u6807\u51c6,\u5426\u5219\u79f0\u4e3a\u547c\u5438\u6682\u505c\u547c\u5438\u4e0d\u8db3\u6307\u6570(AHI)\u3002 \u5728\u8fd9\u4e9b\u8bca\u6240\u8bbf\u95ee\u671f\u95f4\uff0c\u5c06\u5b8c\u6210\u8c03\u67e5\uff0c\u901a\u8fc7\u91c7\u96c6\u8840\u6db2\u6837\u672c\u76d1\u6d4b\u6b21\u8981\u7ec8\u70b9\uff0c\u4ee5\u76d1\u6d4bIncannex\u5019\u9009\u836f\u7269\u7684\u5b89\u5168\u6027\u3002 \u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c Incannex\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u5c06\u5728Alfred\u533b\u9662\u8fdb\u884c\uff0c\u7531\u8d44\u6df1\u9996\u5e2d\u7814\u7a76\u5458Terry O &#8216;Brien\u6559\u6388\u6307\u5bfc\u3002 \u6839\u636e\u8bd5\u9a8c\u7684\u65e2\u5b9a\u76ee\u6807\uff0c\u8fd8\u5c06\u76d1\u6d4b\u53c2\u4e0e\u8005\u7684\u5176\u4ed6\u7ec8\u70b9\uff0c\u5982\u6c27\u9971\u548c\u5ea6\u6307\u6570\u7684\u964d\u4f4e\u3001\u767d\u5929\u7684\u55dc\u7761\u3001\u60c5\u7eea\u548c\u751f\u6d3b\u8d28\u91cf\u3002 \u9274\u4e8e\u201c\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u5728\u766b\u75eb\u60a3\u8005\u4e2d\u6bd4\u666e\u901a\u4eba\u7fa4\u66f4\u666e\u904d\uff0c\u800c\u4e14\u7761\u7720\u8d28\u91cf\u5dee\u4e0e\u766b\u75eb\u53d1\u4f5c\u9891\u7387\u9ad8\u6709\u5173\u201d\uff0c\u8be5\u516c\u53f8\u6307\u51fa\uff0c\u766b\u75eb\u60a3\u8005\u53ef\u80fd\u662f\u8be5\u836f\u6cbb\u7597\u4e2d\u6700\u6025\u6027\u7684\u53d7\u76ca\u8005\u3002 Incannex\u8865\u5145\u8bf4\uff0cO &#8216;Brien\u5148\u751f\u63a5\u89e6\u60a3\u6709\u5171\u75c5\u6027\u766b\u75eb\u548cOSA\u7684\u60a3\u8005\u5c06\u6709\u52a9\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u7684\u8fdb\u5c55\uff0c\u5e76\u4f7f\u516c\u53f8\u80fd\u591f\u8bc4\u4f30IHL-42X\u7597\u6548\u7684\u6539\u5584\u662f\u5426\u4f1a\u964d\u4f4e\u766b\u75eb\u53d1\u4f5c\u7684\u9891\u7387\u3002 \u5982\u679c\u8bd5\u9a8c\u6210\u529f\uff0cIncannex\u5e0c\u671b\u901a\u8fc7\u6fb3\u5927\u5229\u4e9a\u7684\u7279\u6b8a\u51c6\u5165\u8ba1\u5212\uff0c\u5c06IHL-42X\u4e0e\u5927\u9ebb\u7d20\u6cb9\u548cCBD\u5438\u5165\u5668\u4e00\u8d77\u5728\u6fb3\u5927\u5229\u4e9a\u9500\u552e\u3002\u6b64\u540e\uff0c\u8be5\u516c\u53f8\u5e0c\u671b\u8fdb\u884c\u7b2c\u4e8c\u9636\u6bb5\u7684\u201c\u6790\u56e0\u4e34\u5e8a\u8bd5\u9a8c\u201d\uff0c\u56e0\u4e3a\u5b83\u7f16\u8f91\u5fc5\u8981\u7684\u4fe1\u606f\uff0c\u4e3a\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u7684\u65b0\u836f\u7533\u8bf7\uff0c\u4ee5\u5b9e\u73b0\u5728\u7f8e\u56fd\u7684\u5e02\u573a\u72ec\u5360\u6027\u3002 Incannex\u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u58f0\u660e\u4e2d\u8868\u793a\uff0c\u5982\u679cAlfred\u7684\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u79ef\u6781\u7684\u7ed3\u679c\u201d\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6210\u4e3a\u8be5\u516c\u53f8\u201c\u4e3b\u8981\u7684\u4f30\u503c\u8f6c\u6298\u70b9\u201d\u3002 Latham\u8bf4:\u201c\u7761\u7720\u547c\u5438\u6682\u505c\u75c7\u662f\u4e00\u79cd\u5371\u9669\u7684\u75be\u75c5\uff0c\u5bf9\u60a3\u8005\u7684\u5f71\u54cd\u5e7f\u6cdb\uff0c\u76ee\u524d\u7684\u6cbb\u7597\u65b9\u6848\u5bf9\u8bb8\u591a\u4eba\u6765\u8bf4\u4e0d\u5207\u5b9e\u9645\u3002\u201d \u4ed6\u8865\u5145\u8bf4:\u201c\u4e00\u4e2a\u6210\u529f\u7684\u836f\u7269\u89e3\u51b3\u65b9\u6848\u5c06\u5bf9\u8fd9\u79cd\u60c5\u51b5\u7684\u60a3\u8005\u6765\u8bf4\u662f\u9769\u547d\u6027\u7684\uff0c\u6211\u4eec\u671f\u5f85\u7740\u63d0\u4f9b\u4e34\u5e8a\u9879\u76ee\u7684\u66f4\u65b0\uff0c\u56e0\u4e3a\u6211\u4eec\u6b63\u5728\u4e3a\u60a3\u8005\u7ed9\u836f\u6211\u4eec\u72ec\u7279\u7684IHL-42X\u914d\u65b9\u3002\u201d<\/p>\n","protected":false},"author":5,"featured_media":10385,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-20T23:40:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/12\/Incannex-Healthcare-IHL-ASX-first-patients-phase-2-obstructive-sleep-apnoea-clinical-trial.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/12\/Incannex-Healthcare-IHL-ASX-first-patients-phase-2-obstructive-sleep-apnoea-clinical-trial.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/\",\"name\":\"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-12-20T23:40:43+00:00\",\"dateModified\":\"2023-08-29T18:01:54+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c","description":"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c","og_description":"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/","og_site_name":"smallcapsCN","article_published_time":"2020-12-20T23:40:43+00:00","article_modified_time":"2023-08-29T18:01:54+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/12\/Incannex-Healthcare-IHL-ASX-first-patients-phase-2-obstructive-sleep-apnoea-clinical-trial.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c","twitter_description":"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/12\/Incannex-Healthcare-IHL-ASX-first-patients-phase-2-obstructive-sleep-apnoea-clinical-trial.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/","name":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-12-20T23:40:43+00:00","dateModified":"2023-08-29T18:01:54+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"Incannex Healthcare (ASX: IHL)\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u8fdb\u884c\u5176IHL- 42x 2b\u671f\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c(OSA)\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-recruits-ihl-42x-obstructive-sleep-apnoea-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex Healthcare\u62db\u52dfIHL-42X\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2445"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2445"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2445\/revisions"}],"predecessor-version":[{"id":10384,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2445\/revisions\/10384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10385"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}